Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001)
Clinical trial NCT02731742 · TERMINATED
Trial details
- NCT number
- NCT02731742
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2018-01-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.